Loading insider details...
Beta
Latest Form 4 (Jun 18, 2026): Grant/Award of 50,000 FDMT shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 18, 2026 | 4D Molecular Therapeutics, Inc. (FDMT) | Grant/Award | 50,000 | n/a |
| Jun 10, 2026 | Cabaletta Bio, Inc. (CABA) | Grant/Award | 22,000 | n/a |
| Jan 21, 2026 | Cabaletta Bio, Inc. (CABA) | Purchase | 22,725 | $50.3K |
| Jun 20, 2025 | 4D Molecular Therapeutics, Inc. (FDMT) | Grant/Award | 22,500 | n/a |
| Jun 10, 2025 | Cabaletta Bio, Inc. (CABA) | Grant/Award | 22,000 | n/a |
| May 20, 2025 | Cabaletta Bio, Inc. (CABA) | Disposition to Issuer | 44,000 | n/a |
| Jun 7, 2024 | Allovir, Inc. (ALVR) | Grant/Award | 35,000 | n/a |
| Jun 4, 2024 | Cabaletta Bio, Inc. (CABA) | Grant/Award | 22,000 | n/a |
| May 24, 2024 | 4D Molecular Therapeutics, Inc. (FDMT) | Grant/Award | 22,500 | n/a |
| Feb 2, 2024 | Gamida Cell Ltd. (GMDA) | Grant/Award | 200,000 | n/a |